0278/2023 - Sobrevida por câncer de laringe em pacientes tratados no Sistema Único de Saúde - SUS, 2002-2010. Laryngeal cancer survival in patients treated at Brazil’s Unified Health System- SUS2002-2010.
O objetivo deste artigo é analisar a sobrevida de cinco anos em pacientes com câncer de laringe tratados no Sistema Único de Saúde, no Brasil e regiões entre janeiro de 2002 e junho de 2010. No Brasil, são escassas as informações relativas à magnitude e sobrevida do câncer de laringe, o que dificulta a adoção de estratégias específicas para seu controle. Foi realizado um estudo de coorte retrospectiva a partir da Base Nacional em Oncologia. Estimou-se a probabilidade de sobrevida para o câncer de laringe segundo faixa etária, sexo e regiões/estados brasileiros através do método de Kaplan-Meier. O teste de log-rank aplicado para avaliar as diferenças na sobrevida, considerando-se o nível de significância de 5%. A sobrevida no Brasil foi estimada em 50,8% (IC95%:49,9-51,8), sendo menor em pacientes do sexo masculino (49,1%; IC95%:48,10-50,16); com idade entre 50 e 60 anos (48,4%; IC95%:46,7-50,0); e para moradores da região Norte (45,5%; IC95%:39,5-51,3). A variação na sobrevida para o câncer de laringe em relação aos estados e regiões do país aponta disparidades que podem estar relacionadas à desigualdade de acesso ao diagnóstico e/ou tratamento.
Palavras-chave:
Neoplasias Laríngeas; Análise de Sobrevida; Epidemiologia
Abstract:
The objective was to analyze five-year survival for patients with laryngeal cancer treated at the Brazil’s Unified Health System and regions between January 2002 and June 2010. In Brazil, information regarding magnitude and survival of laryngeal cancer, which makes it difficult adopt specific strategies for its control in the country In order to achieve this objective, a retrospective cohort study was conducted based on the National Oncology Database. The probability of survival for laryngeal cancer according to age, sex and Brazilian regions/states was estimated using the Kaplan-Meier method. The log-rank test was used to assess the differences observed, considering a significance level of 5%. Survival in Brazil was estimated at 50.8% (95%CI: 49.9%-51.8%), being lower in male patients (49.1%; 95%CI: 48.10%-50.16%); aged between 50 and 60 years (48.4%; 95%CI: 46.7%-50.0%); and for residents of the Norther region (45.5%; 95%CI: 39.5%-51.3%). The variation in survival for laryngeal cancer in Brazil shows disparities between Brazilian regions/states, may be linked to inequality of access to diagnosis and/or treatment.
Laryngeal cancer survival in patients treated at Brazil’s Unified Health System- SUS2002-2010.
Resumo (abstract):
The objective was to analyze five-year survival for patients with laryngeal cancer treated at the Brazil’s Unified Health System and regions between January 2002 and June 2010. In Brazil, information regarding magnitude and survival of laryngeal cancer, which makes it difficult adopt specific strategies for its control in the country In order to achieve this objective, a retrospective cohort study was conducted based on the National Oncology Database. The probability of survival for laryngeal cancer according to age, sex and Brazilian regions/states was estimated using the Kaplan-Meier method. The log-rank test was used to assess the differences observed, considering a significance level of 5%. Survival in Brazil was estimated at 50.8% (95%CI: 49.9%-51.8%), being lower in male patients (49.1%; 95%CI: 48.10%-50.16%); aged between 50 and 60 years (48.4%; 95%CI: 46.7%-50.0%); and for residents of the Norther region (45.5%; 95%CI: 39.5%-51.3%). The variation in survival for laryngeal cancer in Brazil shows disparities between Brazilian regions/states, may be linked to inequality of access to diagnosis and/or treatment.
Candido, T.C, Guerra, M.R, Teixeira, M.T.B, Nogueira, M.C, Cherchiglia, M. L.. Sobrevida por câncer de laringe em pacientes tratados no Sistema Único de Saúde - SUS, 2002-2010.. Cien Saude Colet [periódico na internet] (2023/Set). [Citado em 19/09/2024].
Está disponível em: http://cienciaesaudecoletiva.com.br/artigos/sobrevida-por-cancer-de-laringe-em-pacientes-tratados-no-sistema-unico-de-saude-sus-20022010/18904?id=18904&id=18904
